This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
A risk entailed in the support of medical journals by advertising and of the meetings of medical societies by the pharmaceutical industry is that the original objective may become secondary to the purposes of highpressure advertising. An an example of this danger several symposia held under the auspices of the New York Academy of Science have been thinly veiled promotional parties in which the influence of Madison Avenue is pitted against dispassionate scientific evaluation of new products. Well-known investigators whose research has been supported by the company producing a drug are brought as guests or consultants of the company. There is nothing inherently wrong in this. The danger of such arrangements is clearly seen in this symposium on antibacterial therapy. The papers in this symposium are of very unequal merit. Some seem objective. Others make one wonder about such a casual approach. But the major offense is contained in the
Bean WB. Symposium on Antibacterial Therapy. Arch Intern Med. 1960;106(6):900–901. doi:10.1001/archinte.1960.03820060152026
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.